Zkusit zdarma
Kura Oncology, Inc.

Kura Oncology, Inc.

KURA
Cena:
$ 10.41
-0.84 (-7.47%)
Valuace
70
Růst
0
Zdraví
50
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors

Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors

6:02 26-05-2026

– Tumor shrinkage observed in 77% of response-evaluable patients, including in heavily pretreated ...

Kura Oncology, Inc. (KURA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Kura Oncology, Inc. (KURA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

21:00 13-05-2026

Kura Oncology, Inc. (KURA) Presents at Bank of America Global Healthcare Conference 2026 Transcript...

Kura Oncology, Inc. (KURA) Q1 2026 Earnings Call Transcript

Kura Oncology, Inc. (KURA) Q1 2026 Earnings Call Transcript

0:20 13-05-2026

Kura Oncology, Inc. (KURA) Q1 2026 Earnings Call Transcript...

Kura Oncology Q1 Earnings Call Highlights

Kura Oncology Q1 Earnings Call Highlights

21:10 12-05-2026

Kura Oncology NASDAQ: KURA reported $5.8 million in first-quarter net product revenue from KOMZIFTI,...

Kura Oncology (KURA) Reports Q1 Loss, Tops Revenue Estimates

Kura Oncology (KURA) Reports Q1 Loss, Tops Revenue Estimates

18:16 12-05-2026

Kura Oncology (KURA) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Es...

Kura Oncology Reports First Quarter 2026 Financial Results

Kura Oncology Reports First Quarter 2026 Financial Results

16:02 12-05-2026

– $5.8 million in KOMZIFTI™ (ziftomenib) net product revenue in first full quarter of commercial...

Kura Oncology to Participate in Bank of America Securities Healthcare Conference

Kura Oncology to Participate in Bank of America Securities Healthcare Conference

7:30 06-05-2026

SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical ...

Kura Oncology to Report First Quarter 2026 Financial Results

Kura Oncology to Report First Quarter 2026 Financial Results

7:30 05-05-2026

SAN DIEGO, May 05, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical ...

Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

11:01 30-04-2026

Kura Oncology (KURA) possesses the right combination of the two key ingredients for a likely earning...

Kura Oncology: Poised For A Lift With Combinations

Kura Oncology: Poised For A Lift With Combinations

12:42 20-04-2026

Kura Oncology, Inc. remains a Buy, driven by ziftomenib's launch and promising combination trial dat...

KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data

KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data

11:26 20-04-2026

Kura Oncology shares jump 8% as FIT-001 data show strong tumor response and disease control with dar...

Kura Oncology (KURA) Moves 8.3% Higher: Will This Strength Last?

Kura Oncology (KURA) Moves 8.3% Higher: Will This Strength Last?

8:27 20-04-2026

Kura Oncology (KURA) saw its shares surge in the last session with trading volume being higher than ...

Kura Oncology (NASDAQ:KURA) Trading Up 9.7% – Here’s What Happened

Kura Oncology (NASDAQ:KURA) Trading Up 9.7% – Here’s What Happened

3:59 19-04-2026

Shares of Kura Oncology, Inc. (NASDAQ: KURA - Get Free Report) were up 9.7% during mid-day trading o...

Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell Carcinoma Transcript

Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Advanced Renal Cell Carcinoma Transcript

15:31 17-04-2026

Kura Oncology, Inc. (KURA) Discusses Updated Data on Darlifarnib and Cabozantinib Combination in Adv...

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib

6:00 17-04-2026

Data from subset analysis of cabozantinib-pretreated patients support potential to overcome resistan...

Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026

Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026

7:30 09-04-2026

Data build on findings presented at ESMO 2025 and support potential of darlifarnib to overcome resis...

Kura Oncology, Inc. $KURA Shares Bought by SG Americas Securities LLC

Kura Oncology, Inc. $KURA Shares Bought by SG Americas Securities LLC

5:05 07-04-2026

SG Americas Securities LLC grew its stake in Kura Oncology, Inc. (NASDAQ: KURA) by 214.1% in the und...

Kura Oncology: Commercialization In AML Presents Asymmetric Upside

Kura Oncology: Commercialization In AML Presents Asymmetric Upside

8:15 02-04-2026

Kura Oncology (KURA) is reiterated as a Strong Buy, leveraging Komzifti's differentiated safety prof...

Kura Oncology, Inc. (KURA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Kura Oncology, Inc. (KURA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

16:02 12-03-2026

Kura Oncology, Inc. (KURA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript...

Kura Oncology Q4 Earnings Call Highlights

Kura Oncology Q4 Earnings Call Highlights

4:49 07-03-2026

Kura Oncology (NASDAQ: KURA) executives used the company's fourth-quarter and fiscal 2025 earnings c...

close

KURA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

06-02-2026
SAN DIEGO, FEB. 06, 2026 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (THE “COMPANY”) (NASDAQ: KURA),...
Více zde

KURA ONCOLOGY HIGHLIGHTS RECENT ACCOMPLISHMENTS, PRELIMINARY KOMZIFTI REVENUE AND ANTICIPATED 2026 MILESTONES

11-01-2026
– LAUNCHED KOMZIFTI ™ (ZIFTOMENIB), FIRST AND ONLY ONCE-DAILY, ORAL MENIN INHIBITOR APPROVED FOR...
Více zde

KURA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

05-01-2026
SAN DIEGO, JAN. 05, 2026 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (THE “COMPANY”) (NASDAQ: KURA),...
Více zde

KURA ONCOLOGY AND KYOWA KIRIN REPORT COMBINATION DATA FOR KOMZIFTI™ (ZIFTOMENIB) WITH VENETOCLAX AND AZACITIDINE IN NEWLY DIAGNOSED AND RELAPSED/REFRACTORY AML

08-12-2025
– 86% (32/37) CRC AND 73% (27/37) CR IN NEWLY DIAGNOSED NPM1-M AML, WITH 68% (17/25) OF CRC RESPON...
Více zde

KURA ONCOLOGY TO HOST VIRTUAL INVESTOR EVENT TO DISCUSS DATA PRESENTED AT ASH 2025 ON TRIPLET COMBINATION OF ZIFTOMENIB (KOMZIFTI®) WITH VENETOCLAX AND AZACITIDINE IN NEWLY DIAGNOSED AND RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

03-12-2025
SAN DIEGO, DEC. 03, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (NASDAQ: KURA), A BIOPHARMACEUTICAL...
Více zde

FIRST U.S. COMMERCIAL SALE OF KOMZIFTI™ TRIGGERS $135 MILLION MILESTONE PAYMENT TO KURA ONCOLOGY UNDER COLLABORATION AND LICENSE AGREEMENT WITH KYOWA KIRIN

02-12-2025
SAN DIEGO, DEC. 02, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (NASDAQ: KURA, “KURA”), A BIOP...
Více zde

KOMZIFTI™ (ZIFTOMENIB) ADDED TO NATIONAL COMPREHENSIVE CANCER NETWORK® (NCCN) GUIDELINES FOR ACUTE MYELOID LEUKEMIA (AML)

25-11-2025
KOMZIFTI, THE FIRST AND ONLY ONCE-DAILY FDA-APPROVED MENIN INHIBITOR FOR R/R NPM1-MUTATED AML, IS NO...
Více zde

KURA ONCOLOGY AND KYOWA KIRIN ANNOUNCE FDA APPROVAL OF KOMZIFTI™ (ZIFTOMENIB), THE FIRST AND ONLY ONCE-DAILY TARGETED THERAPY FOR ADULTS WITH RELAPSED OR REFRACTORY NPM1-MUTATED ACUTE MYELOID LEUKEMIA

13-11-2025
– NPM1 MUTATIONS, ONE OF THE MOST COMMON GENETIC DRIVERS OF AML, ARE NOW ACTIONABLE FOR PATIENTS ...
Více zde

KURA ONCOLOGY TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCE

12-11-2025
SAN DIEGO, NOV. 12, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (NASDAQ: KURA), A CLINICAL-STAGE BI...
Více zde

KURA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

07-11-2025
SAN DIEGO, NOV. 07, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (THE “COMPANY”) (NASDAQ: KURA),...
Více zde

KURA ONCOLOGY REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

04-11-2025
– NEW DRUG APPLICATION FOR ZIFTOMENIB IN ADULTS WITH R/R NPM1-M AML REMAINS UNDER FDA PRIORITY REV...
Více zde

KURA ONCOLOGY RECEIVES SECOND $30 MILLION DEVELOPMENT MILESTONE PAYMENT IN AML MENIN INHIBITOR PROGRAM WITH KYOWA KIRIN

03-11-2025
– MILESTONE TRIGGERED BY DOSING OF FIRST PATIENT IN THE SECOND OF TWO FRONTLINE AML PHASE 3 CLINIC...
Více zde

KURA ONCOLOGY AND KYOWA KIRIN ANNOUNCE PRESENTATIONS OF ZIFTOMENIB VEN/AZA COMBINATION DATA IN FRONTLINE AND RELAPSED/REFRACTORY NPM1-M OR KMT2A-R ACUTE MYELOID LEUKEMIA AT 2025 ASH ANNUAL MEETING

03-11-2025
– DATA TO BE FEATURED IN TWO ORAL PRESENTATIONS ON DECEMBER 8, 2025 – – BROAD DEVELOPMENT PROG...
Více zde

KURA ONCOLOGY TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS

28-10-2025
SAN DIEGO, OCT. 28, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (NASDAQ: KURA), A CLINICAL-STAGE BI...
Více zde

KURA ONCOLOGY RECEIVES $30 MILLION DEVELOPMENT MILESTONE PAYMENT IN ZIFTOMENIB AML PROGRAM WITH KYOWA KIRIN

24-10-2025
- MILESTONE TRIGGERED BY DOSING OF FIRST PATIENT IN FRONTLINE AML PHASE 3 CLINICAL PROGRAM-  SAN DI...
Více zde

KURA ONCOLOGY ANNOUNCES PRELIMINARY DATA FROM ITS FARNESYL TRANSFERASE INHIBITOR (FTI) PROGRAMS AT THE 2025 EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) CONGRESS

18-10-2025
FTI MECHANISM ADDRESSES INNATE AND ADAPTIVE RESISTANCE PATHWAYS COMMON TO TARGETED ONCOLOGY THERAPIE...
Více zde

KURA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-10-2025
SAN DIEGO, OCT. 03, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (THE “COMPANY”) (NASDAQ: KURA),...
Více zde

KURA ONCOLOGY AND KYOWA KIRIN LAUNCH CLINICAL TRIAL EVALUATING DUAL INHIBITION OF NPM1 AND FLT3 MUTATIONS IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)

01-10-2025
– EXPANDING CLINICAL EXPERIENCE AND SAFETY PROFILE OF ZIFTOMENIB SUPPORT ITS EVALUATION IN COMBINA...
Více zde

KURA ONCOLOGY AND KYOWA KIRIN ANNOUNCE FIRST PATIENT DOSED IN PIVOTAL PHASE 3 KOMET-017 TRIAL OF ZIFTOMENIB FOR FRONTLINE ACUTE MYELOID LEUKEMIA (AML)

29-09-2025
– KOMET-017-IC TRIAL OF INTENSIVE CHEMOTHERAPY COMBINATION WILL ASSESS MRD NEGATIVE CR AND EFS AS ...
Více zde

KURA ONCOLOGY AND KYOWA KIRIN ANNOUNCE PUBLICATION OF PIVOTAL ZIFTOMENIB DATA IN RELAPSED/REFRACTORY NPM1-MUTATED AML IN THE JOURNAL OF CLINICAL ONCOLOGY

25-09-2025
– KOMET-001 IN R/R NPM1-M AML MET ITS PRIMARY ENDPOINT WITH ZIFTOMENIB MONOTHERAPY DEMONSTRATING S...
Více zde

KURA ONCOLOGY TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCE

24-09-2025
SAN DIEGO, SEPT. 24, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (NASDAQ: KURA), A CLINICAL-STAGE B...
Více zde

KURA ONCOLOGY HIGHLIGHTS PRECLINICAL DATA DEMONSTRATING POTENTIAL OF FARNESYL TRANSFERASE INHIBITORS TO OVERCOME DRUG RESISTANCE IN COMBINATION WITH KEY TARGETED THERAPIES ACROSS MULTIPLE TUMOR TYPES

16-09-2025
ANALYST/INVESTOR EVENT SHOWCASES OPPORTUNITIES FOR KO-2806 (DARLIFARNIB) IN COMBINATION WITH PI3KΑ ...
Více zde

KURA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

05-09-2025
SAN DIEGO, SEPT. 05, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (THE “COMPANY”) (NASDAQ: KURA)...
Více zde

KURA ONCOLOGY TO HOST VIRTUAL INVESTOR AND ANALYST EVENTS ON FARNESYL TRANSFERASE INHIBITOR PROGRAM

03-09-2025
SEPTEMBER 16 EVENT TO HIGHLIGHT PRECLINICAL DATA ON THE COMBINATION OF FTI AGENTS WITH MULTIPLE CLAS...
Více zde

KURA ONCOLOGY TO PARTICIPATE IN THREE UPCOMING INVESTOR CONFERENCES

28-08-2025
SAN DIEGO, AUG. 28, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (NASDAQ: KURA), A CLINICAL-STAGE BI...
Více zde

KURA ONCOLOGY REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

07-08-2025
– FDA PRIORITY REVIEW OF NEW DRUG APPLICATION (NDA) FOR ZIFTOMENIB IN ADULTS WITH R/R NPM1-M AML W...
Více zde

KURA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

04-08-2025
SAN DIEGO, AUG. 04, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (THE “COMPANY”) (NASDAQ: KURA),...
Více zde

KURA ONCOLOGY TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS

31-07-2025
SAN DIEGO, JULY 31, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (NASDAQ: KURA), A CLINICAL-STAGE BI...
Více zde

KURA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-07-2025
SAN DIEGO, JULY 03, 2025 (GLOBE NEWSWIRE) -- KURA ONCOLOGY, INC. (THE “COMPANY”) (NASDAQ: KURA),...
Více zde

KURA ONCOLOGY AND KYOWA KIRIN REPORT POSITIVE UPDATED COMBINATION DATA FOR ZIFTOMENIB IN NEWLY DIAGNOSED AML AT 2025 EUROPEAN HEMATOLOGY ASSOCIATION CONGRESS

12-06-2025
– ENCOURAGING CLINICAL ACTIVITY WITH DEEP RESPONSES DEMONSTRATED IN THE KOMET-007 TRIAL WITH THE C...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-29 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-12-02 00:00:008-KStáhnout
2025-11-13 00:00:008-KStáhnout
2025-11-04 00:00:008-KStáhnout
2025-11-04 00:00:0010-QStáhnout
2025-10-24 01:00:008-KStáhnout
2025-10-24 00:00:008-KStáhnout
2025-10-16 01:00:008-KStáhnout
2025-10-16 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-07-01 01:00:008-KStáhnout
2025-07-01 00:00:008-KStáhnout
2025-06-18 01:00:008-KStáhnout
2025-06-18 00:00:008-KStáhnout
2025-06-06 01:00:008-KStáhnout
2025-06-06 00:00:008-KStáhnout
2025-06-03 01:00:008-KStáhnout
2025-06-03 00:00:008-KStáhnout
2025-05-01 01:00:008-KStáhnout
2025-05-01 01:00:0010-QStáhnout
2025-05-01 00:00:008-KStáhnout
2025-05-01 00:00:0010-QStáhnout
2025-02-28 00:00:0010-KStáhnout
2025-02-27 23:00:0010-KStáhnout
2025-02-26 00:00:008-KStáhnout
2025-02-25 23:00:008-KStáhnout
2025-02-05 00:00:008-KStáhnout
2025-02-04 23:00:008-KStáhnout
2025-01-14 00:00:008-KStáhnout
2025-01-13 23:00:008-KStáhnout
2025-01-06 00:00:008-KStáhnout
2025-01-05 23:00:008-KStáhnout
2024-12-20 00:00:008-KStáhnout
2024-12-19 23:00:008-KStáhnout
2024-11-20 00:00:008-KStáhnout
2024-11-19 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-09-17 01:00:008-KStáhnout
2024-09-17 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-07 01:00:008-KStáhnout
2024-06-07 00:00:008-KStáhnout
2024-05-24 01:00:008-KStáhnout
2024-05-24 00:00:008-KStáhnout
2024-05-02 01:00:008-KStáhnout
2024-05-02 01:00:0010-QStáhnout
2024-05-02 00:00:008-KStáhnout
2024-05-02 00:00:0010-QStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-27 00:00:0010-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 23:00:0010-KStáhnout
2024-01-30 00:00:008-KStáhnout
2024-01-29 23:00:008-KStáhnout
2024-01-26 00:00:008-KStáhnout
2024-01-25 23:00:008-KStáhnout
2023-12-22 00:00:008-KStáhnout
2023-12-21 23:00:008-KStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:008-KStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-09-01 01:00:008-KStáhnout
2023-09-01 00:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 00:00:008-KStáhnout
2023-06-14 01:00:008-KStáhnout
2023-06-14 00:00:008-KStáhnout
2023-06-12 01:00:008-KStáhnout
2023-06-12 00:00:008-KStáhnout
2023-06-02 01:00:008-KStáhnout
2023-06-02 00:00:008-KStáhnout
2023-05-10 01:00:008-KStáhnout
2023-05-10 01:00:0010-QStáhnout
2023-05-10 00:00:008-KStáhnout
2023-05-10 00:00:0010-QStáhnout
2023-04-19 01:00:008-KStáhnout
2023-04-19 00:00:008-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-23 00:00:0010-KStáhnout
2023-02-22 23:00:008-KStáhnout
2023-02-22 23:00:0010-KStáhnout
2023-01-13 00:00:008-KStáhnout
2023-01-12 23:00:008-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-12-12 00:00:008-KStáhnout
2022-12-11 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-09-29 01:00:008-KStáhnout
2022-09-29 00:00:008-KStáhnout
2022-08-03 01:00:008-KStáhnout
2022-08-03 01:00:0010-QStáhnout
2022-08-03 00:00:008-KStáhnout
2022-08-03 00:00:0010-QStáhnout
2022-06-23 01:00:008-KStáhnout
2022-06-23 00:00:008-KStáhnout
2022-05-04 01:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:008-KStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-24 00:00:0010-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-02-23 23:00:0010-KStáhnout
2022-02-01 00:00:008-KStáhnout
2022-01-31 23:00:008-KStáhnout
2022-01-20 00:00:008-KStáhnout
2022-01-19 23:00:008-KStáhnout
2021-11-24 00:00:008-KStáhnout
2021-11-23 23:00:008-KStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-04 00:00:0010-QStáhnout
2021-11-03 23:00:008-KStáhnout
2021-11-03 23:00:0010-QStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-07-29 01:00:008-KStáhnout
2021-07-29 00:00:008-KStáhnout
2021-06-25 01:00:008-KStáhnout
2021-06-25 00:00:008-KStáhnout
2021-06-04 01:00:008-KStáhnout
2021-06-04 00:00:008-KStáhnout
2021-05-24 01:00:008-KStáhnout
2021-05-24 00:00:008-KStáhnout
2021-05-17 01:00:008-KStáhnout
2021-05-17 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-02-24 00:00:008-KStáhnout
2021-02-24 00:00:0010-KStáhnout
2021-02-23 23:00:008-KStáhnout
2021-02-23 23:00:0010-KStáhnout
2021-01-08 00:00:008-KStáhnout
2021-01-07 23:00:008-KStáhnout
2020-12-09 00:00:008-KStáhnout
2020-12-08 23:00:008-KStáhnout
2020-12-07 00:00:008-KStáhnout
2020-12-06 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-11-04 00:00:008-KStáhnout
2020-11-03 23:00:008-KStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-06-26 01:00:008-KStáhnout
2020-06-26 00:00:008-KStáhnout
2020-05-29 01:00:008-KStáhnout
2020-05-29 00:00:008-KStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 00:00:008-KStáhnout
2020-05-04 01:00:008-KStáhnout
2020-05-04 01:00:0010-QStáhnout
2020-05-04 00:00:008-KStáhnout
2020-05-04 00:00:0010-QStáhnout
2020-04-24 01:00:008-KStáhnout
2020-04-24 00:00:008-KStáhnout
2020-04-07 01:00:008-KStáhnout
2020-04-07 00:00:008-KStáhnout
2020-03-26 00:00:008-KStáhnout
2020-03-25 23:00:008-KStáhnout
2020-03-04 00:00:008-KStáhnout
2020-03-03 23:00:008-KStáhnout
2020-02-25 00:00:008-KStáhnout
2020-02-25 00:00:0010-KStáhnout
2020-02-24 23:00:008-KStáhnout
2020-02-24 23:00:0010-KStáhnout
2020-01-23 00:00:008-KStáhnout
2020-01-22 23:00:008-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2020-01-10 00:00:008-KStáhnout
2020-01-09 23:00:008-KStáhnout
2019-12-16 00:00:008-KStáhnout
2019-12-15 23:00:008-KStáhnout
2019-12-09 00:00:008-KStáhnout
2019-12-08 23:00:008-KStáhnout
2019-11-05 00:00:008-KStáhnout
2019-11-05 00:00:0010-QStáhnout
2019-11-04 23:00:008-KStáhnout
2019-11-04 23:00:0010-QStáhnout
2019-10-30 00:00:008-KStáhnout
2019-10-29 23:00:008-KStáhnout
2019-10-15 01:00:008-KStáhnout
2019-10-15 00:00:008-KStáhnout
2019-09-03 01:00:008-KStáhnout
2019-09-03 00:00:008-KStáhnout
2019-08-12 01:00:008-KStáhnout
2019-08-12 00:00:008-KStáhnout
2019-08-01 01:00:008-KStáhnout
2019-08-01 01:00:0010-QStáhnout
2019-08-01 00:00:008-KStáhnout
2019-08-01 00:00:0010-QStáhnout
2019-06-27 01:00:008-KStáhnout
2019-06-27 00:00:008-KStáhnout
2019-06-19 01:00:008-KStáhnout
2019-06-19 00:00:008-KStáhnout
2019-06-14 01:00:008-KStáhnout
2019-06-14 00:00:008-KStáhnout
2019-05-07 01:00:008-KStáhnout
2019-05-07 01:00:0010-QStáhnout
2019-05-07 00:00:008-KStáhnout
2019-05-07 00:00:0010-QStáhnout
2019-03-05 00:00:008-KStáhnout
2019-03-05 00:00:0010-KStáhnout
2019-03-04 23:00:008-KStáhnout
2019-03-04 23:00:0010-KStáhnout
2019-01-07 00:00:008-KStáhnout
2019-01-06 23:00:008-KStáhnout
2018-12-03 00:00:008-KStáhnout
2018-12-02 23:00:008-KStáhnout
2018-11-08 00:00:008-KStáhnout
2018-11-07 23:00:008-KStáhnout
2018-11-05 00:00:008-KStáhnout
2018-11-05 00:00:0010-QStáhnout
2018-11-04 23:00:008-KStáhnout
2018-11-04 23:00:0010-QStáhnout
2018-10-22 01:00:008-KStáhnout
2018-10-22 00:00:008-KStáhnout
2018-08-06 01:00:008-KStáhnout
2018-08-06 01:00:0010-QStáhnout
2018-08-06 00:00:008-KStáhnout
2018-08-06 00:00:0010-QStáhnout
2018-07-31 01:00:008-KStáhnout
2018-07-31 00:00:008-KStáhnout
2018-07-02 01:00:008-KStáhnout
2018-07-02 00:00:008-KStáhnout
2018-06-28 01:00:008-KStáhnout
2018-06-28 00:00:008-KStáhnout
2018-06-20 01:00:008-KStáhnout
2018-06-20 00:00:008-KStáhnout
2018-06-11 01:00:008-KStáhnout
2018-06-11 00:00:008-KStáhnout
2018-05-08 01:00:008-KStáhnout
2018-05-08 01:00:0010-QStáhnout
2018-05-08 00:00:008-KStáhnout
2018-05-08 00:00:0010-QStáhnout
2018-03-12 00:00:008-KStáhnout
2018-03-12 00:00:0010-KStáhnout
2018-03-11 23:00:008-KStáhnout
2018-03-11 23:00:0010-KStáhnout
2018-02-16 00:00:008-KStáhnout
2018-02-15 23:00:008-KStáhnout
2018-01-24 00:00:008-KStáhnout
2018-01-23 23:00:008-KStáhnout
2017-11-09 00:00:008-KStáhnout
2017-11-08 23:00:008-KStáhnout
2017-11-07 00:00:008-KStáhnout
2017-11-07 00:00:0010-QStáhnout
2017-11-06 23:00:008-KStáhnout
2017-11-06 23:00:0010-QStáhnout
2017-09-07 01:00:008-KStáhnout
2017-09-07 00:00:008-KStáhnout
2017-08-11 01:00:008-KStáhnout
2017-08-11 00:00:008-KStáhnout
2017-08-07 01:00:008-KStáhnout
2017-08-07 01:00:0010-QStáhnout
2017-08-07 00:00:008-KStáhnout
2017-08-07 00:00:0010-QStáhnout
2017-06-14 01:00:008-KStáhnout
2017-06-14 00:00:008-KStáhnout
2017-05-25 01:00:008-KStáhnout
2017-05-25 00:00:008-KStáhnout
2017-05-15 01:00:008-KStáhnout
2017-05-15 01:00:0010-QStáhnout
2017-05-15 00:00:008-KStáhnout
2017-05-15 00:00:0010-QStáhnout
2017-03-14 00:00:008-KStáhnout
2017-03-14 00:00:0010-KStáhnout
2017-03-13 23:00:008-KStáhnout
2017-03-13 23:00:0010-KStáhnout
2017-03-06 00:00:008-KStáhnout
2017-03-05 23:00:008-KStáhnout
2017-01-27 00:00:008-KStáhnout
2017-01-26 23:00:008-KStáhnout
2017-01-03 00:00:008-KStáhnout
2017-01-02 23:00:008-KStáhnout
2016-12-22 00:00:008-KStáhnout
2016-12-21 23:00:008-KStáhnout
2016-11-07 00:00:008-KStáhnout
2016-11-07 00:00:0010-QStáhnout
2016-11-06 23:00:008-KStáhnout
2016-11-06 23:00:0010-QStáhnout
2016-08-10 01:00:008-KStáhnout
2016-08-10 01:00:0010-QStáhnout
2016-08-10 00:00:008-KStáhnout
2016-08-10 00:00:0010-QStáhnout
2016-06-16 01:00:008-KStáhnout
2016-06-16 00:00:008-KStáhnout
2016-06-13 01:00:008-KStáhnout
2016-06-13 00:00:008-KStáhnout
2016-06-06 01:00:008-KStáhnout
2016-06-06 00:00:008-KStáhnout
2016-05-16 01:00:008-KStáhnout
2016-05-16 00:00:008-KStáhnout
2016-05-11 01:00:008-KStáhnout
2016-05-11 01:00:0010-QStáhnout
2016-05-11 00:00:008-KStáhnout
2016-05-11 00:00:0010-QStáhnout
2016-04-29 01:00:008-KStáhnout
2016-04-29 00:00:008-KStáhnout
2016-03-17 00:00:008-KStáhnout
2016-03-17 00:00:0010-KStáhnout
2016-03-16 23:00:008-KStáhnout
2016-03-16 23:00:0010-KStáhnout
2016-02-10 00:00:008-KStáhnout
2016-02-09 23:00:008-KStáhnout
2016-02-04 00:00:008-KStáhnout
2016-02-03 23:00:008-KStáhnout
2015-11-13 00:00:0010-QStáhnout
2015-11-12 23:00:0010-QStáhnout
2015-10-20 01:00:008-KStáhnout
2015-10-20 00:00:008-KStáhnout
2015-10-14 01:00:008-KStáhnout
2015-10-14 00:00:008-KStáhnout
2015-08-14 01:00:0010-QStáhnout
2015-08-14 00:00:0010-QStáhnout
2015-08-11 01:00:008-KStáhnout
2015-08-11 00:00:008-KStáhnout
2015-08-06 01:00:008-KStáhnout
2015-08-06 00:00:008-KStáhnout
2015-05-13 01:00:0010-QStáhnout
2015-05-13 00:00:0010-QStáhnout
2015-04-27 01:00:008-KStáhnout
2015-04-27 00:00:008-KStáhnout
2015-03-12 00:00:008-KStáhnout
2015-03-11 23:00:008-KStáhnout
2015-02-27 00:00:0010-KStáhnout
2015-02-26 23:00:0010-KStáhnout
2014-11-14 00:00:0010-QStáhnout
2014-11-13 23:00:0010-QStáhnout
2014-08-14 01:00:0010-QStáhnout
2014-08-14 00:00:0010-QStáhnout
2014-05-15 01:00:0010-QStáhnout
2014-05-15 00:00:0010-QStáhnout
2014-03-31 01:00:0010-KStáhnout
2014-03-31 00:00:0010-KStáhnout
2013-11-14 00:00:0010-QStáhnout
2013-11-13 23:00:0010-QStáhnout
2013-08-14 01:00:0010-QStáhnout
2013-08-14 00:00:0010-QStáhnout
2013-05-15 01:00:0010-QStáhnout
2013-05-15 00:00:0010-QStáhnout
2013-03-28 00:00:0010-KStáhnout
2013-03-27 23:00:0010-KStáhnout
2012-11-14 00:00:0010-QStáhnout
2012-11-13 23:00:0010-QStáhnout
2012-08-14 01:00:0010-QStáhnout
2012-08-14 00:00:0010-QStáhnout
2012-05-15 01:00:0010-QStáhnout
2012-05-15 00:00:0010-QStáhnout
2012-03-30 01:00:0010-KStáhnout
2012-03-30 00:00:0010-KStáhnout
2011-11-14 00:00:0010-QStáhnout
2011-11-13 23:00:0010-QStáhnout
2011-08-15 01:00:0010-QStáhnout
2011-08-15 00:00:0010-QStáhnout
2011-05-16 01:00:0010-QStáhnout
2011-05-16 00:00:0010-QStáhnout
2011-03-31 01:00:0010-KStáhnout
2011-03-31 00:00:0010-KStáhnout
2010-11-15 00:00:0010-QStáhnout
2010-11-14 23:00:0010-QStáhnout
2010-08-13 01:00:0010-QStáhnout
2010-08-13 00:00:0010-QStáhnout
2010-05-17 01:00:0010-QStáhnout
2010-05-17 00:00:0010-QStáhnout
2010-03-31 01:00:0010-KStáhnout
2010-03-31 00:00:0010-KStáhnout
2009-11-16 00:00:0010-QStáhnout
2009-11-15 23:00:0010-QStáhnout
2009-08-14 01:00:0010-QStáhnout
2009-08-14 00:00:0010-QStáhnout
2009-05-15 01:00:0010-QStáhnout
2009-05-15 00:00:0010-QStáhnout
2009-03-31 01:00:0010-KStáhnout
2009-03-31 00:00:0010-KStáhnout
2008-11-12 00:00:0010-QStáhnout
2008-11-11 23:00:0010-QStáhnout
preloader